KRAS and sarcoma: We also showed that the epithelial and sarcomatoid components of the microdissection samples shared driver mutations (such as KRAS and EGFR mutations) that were commonly observed in conventional lung cancer but were rare in sarcoma, further emphasizing the true epithelial nature of PSC and suggesting that the transformation of the epithelial components might occur first.